Orgenesis Probability of Future OTC Stock Price Finishing Over 6.85
| ORGSDelisted Stock | USD 1.22 0.31 20.26% |
Orgenesis |
Orgenesis Target Price Odds to finish over 6.85
The tendency of Orgenesis OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 6.85 or more in 90 days |
| 1.22 | 90 days | 6.85 | about 30.12 |
Based on a normal probability distribution, the odds of Orgenesis to move over $ 6.85 or more in 90 days from now is about 30.12 (This Orgenesis probability density function shows the probability of Orgenesis OTC Stock to fall within a particular range of prices over 90 days) . Probability of Orgenesis price to stay between its current price of $ 1.22 and $ 6.85 at the end of the 90-day period is about 69.14 .
Given the investment horizon of 90 days Orgenesis has a beta of -4.43. This indicates as returns on its benchmark rise, returns on holding Orgenesis are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Orgenesis is expected to outperform its benchmark. Additionally Orgenesis has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Orgenesis Price Density |
| Price |
Predictive Modules for Orgenesis
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Orgenesis. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Orgenesis Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Orgenesis is not an exception. The market had few large corrections towards the Orgenesis' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Orgenesis, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Orgenesis within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.78 | |
β | Beta against Dow Jones | -4.43 | |
σ | Overall volatility | 1.90 | |
Ir | Information ratio | -0.17 |
Orgenesis Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Orgenesis for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Orgenesis can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Orgenesis is not yet fully synchronised with the market data | |
| Orgenesis generated a negative expected return over the last 90 days | |
| Orgenesis has high historical volatility and very poor performance | |
| Orgenesis may become a speculative penny stock | |
| Orgenesis has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 530 K. Net Loss for the year was (64.92 M) with profit before overhead, payroll, taxes, and interest of 36.02 M. | |
| Orgenesis currently holds about 2.3 M in cash with (14.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
Orgenesis Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Orgenesis OTC Stock often depends not only on the future outlook of the current and potential Orgenesis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orgenesis' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29 M | |
| Cash And Short Term Investments | 837 K |
Orgenesis Technical Analysis
Orgenesis' future price can be derived by breaking down and analyzing its technical indicators over time. Orgenesis OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orgenesis. In general, you should focus on analyzing Orgenesis OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Orgenesis Predictive Forecast Models
Orgenesis' time-series forecasting models is one of many Orgenesis' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Orgenesis' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Orgenesis
Checking the ongoing alerts about Orgenesis for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Orgenesis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Orgenesis is not yet fully synchronised with the market data | |
| Orgenesis generated a negative expected return over the last 90 days | |
| Orgenesis has high historical volatility and very poor performance | |
| Orgenesis may become a speculative penny stock | |
| Orgenesis has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 530 K. Net Loss for the year was (64.92 M) with profit before overhead, payroll, taxes, and interest of 36.02 M. | |
| Orgenesis currently holds about 2.3 M in cash with (14.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Orgenesis OTC Stock
If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |